Not finding it? Sign in to also search OpenAlex live.
-
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma2025 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Meningioma and schwannoma management Open access
Maximilian Johannes Mair, Sabrina Hartenbach, Erwin Tomasich, Sybren L. N. Maas, Georg Widhalm, Franziska Eckert, +6 more
9citations -
CCTG EN10: A phase II study of tailored adjuvant therapy in POLE-mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)—RAINBO BLUE and TAPER.2023 Journal of Clinical Oncology conference-abstract Medicine Endometrial and Cervical Cancer Treatments Open access
Jessica Nell McAlpine, Kathy Chai-Zung Han, Mary A. Kinloch, Maroie Barkati, Sarah Elizabeth Ferguson, Anthony Fyles, +13 more
8citations -
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines2021 Annals of Surgical Treatment and Research article Medicine Thyroid Cancer Diagnosis and Treatment Open access
Kyoung Sik Park, Madhuri Saindane, Eun Yeol Yang, Tong Yi Jin, Harikrishna Reddy Rallabandi, Alexander Heil, +7 more
7citations -
Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alpha2023 Research Square preprint Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Milena Kalmer, Martin Graßhoff, Tiago Maié, Kristina Pannen, Marcelo A. S. Toledo, Margherita Vieri, +13 more
2citations -
Overall survival and long-term safety with ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: Final analyses from INTRIGUE.2024 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
John Raymond Zalcberg, Robin L. Jones, Jean‐Yves Blay, Suzanne George, Hans A. J. Gelderblom, Patrick Schöffski, +12 more
2citations -
Overall survival and long-term safety in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: Updated analyses from INTRIGUE.2023 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Robin L. Jones, Jean‐Yves Blay, Suzanne George, Hans A. J. Gelderblom, Patrick Schöffski, Margaret von Mehren, +12 more
1citations -
Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP2023 Climacteric article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
R. F. M. Vermeulen, J. L. van Altena, Katja N. Gaarenstroom, Marc van Beurden, J. K. Kieffer, Neil K. Aaronson, +2 more
0citations -
Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol
Karlijn Verkerk, Soemeya F. Haj Mohammad, Laurien Joanna Zeverijn, Birgit S. Geurts, Ilse A.C. Spiekman, Florentine A.J. Verbeek, +12 more
2citations -
Lower-dosing ponatinib in pre-treated GIST: Results of the POETIG phase II trial.2020 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Johanna Falkenhorst, Rainer Hamacher, Peter Reichardt, Philipp Ivanyi, Bernd Kasper, Peter Hohenberger, +6 more
6citations -
Mutational heterogeneity of imatinib resistance and efficacy of ripretinib vs sunitinib in patients with gastrointestinal stromal tumor: ctDNA analysis from INTRIGUE.2023 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Sebastian Bauer, Robin L. Jones, Suzanne George, Hans A. J. Gelderblom, Patrick Schöffski, Margaret von Mehren, +13 more
16citations -
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study2024 Journal of Clinical Oncology article Medicine Lung Cancer Treatments and Mutations Open access cited by 3 patents
Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna Rachel Minchom, Melina Elpi Marmarelis, +65 more
132citations -
Mutational meltdown of putative microbial altruists in Streptomyces coelicolor colonies2022 Nature Communications article Biochemistry, Genetics and Molecular Biology Evolution and Genetic Dynamics Open access
Zheren Zhang, Shraddha Shitut, Bart Claushuis, Dennis Claessen, Daniel E. Rozen
28citations -
Data-driven framework for input/output lookup tables reduction: Application to hypersonic flows in chemical non-equilibrium2022 RWTH Publications (RWTH Aachen) article Physics and Astronomy Model Reduction and Neural Networks Open access
Clément Scherding, Georgios Rigas, Denis Sipp, Peter J. Schmid, Taraneh Sayadi
1citations -
141TiP Cemiplimab treatment in patients with locally advanced and metastatic secondary angiosarcomas (CEMangio): A phase II clinical trial in progress
Stefan G. van Ravensteijn, Jacco Juri de Haan, Hans A. J. Gelderblom, Yvonne M.H. Versleijen‐Jonkers, Frank M. Speetjens, Suzanne E. J. Kaal, +3 more
0citations